The COVID-19 vaccine will be available as soon as December this year
A large US pharmaceutical company announced that the third phase of the clinical trial report of the COVID-19 vaccine showed that the effective prevention rate of the vaccine was as high as 90%, which was far higher than the 50% requirement of the US Food and Drug Administration (FDA). The pharmaceutical company pointed out that there were 43,538 participants in the test, 94 of whom were confirmed to be infected with the new coronavirus. However, the number of people still infected with the virus has not been announced. The market estimates that if the test process goes smoothly, the vaccine will be available as early as 12 this year. Available at the beginning of the month.
Z. com Bullion is an affiliate of GMO Financial Holdings, Inc., a Japanese listed group. The risk of loss in leveraged foreign exchange trading & margin trading can be substantial. Visit the company website to read full risk warning. https://bullion.z.com/en/about/legal/risk/
場外式黃金/白銀交易由 Max Online 提供。場外式黃金/白銀交易涉及高度風險,未必適合所有投資者。高度的槓桿可為閣下帶來負面或正面的影響。場外式黃金/白銀並非受證券及期貨事務監察委員會(「證監會」)監管,因此買賣場外式黃金/白銀將不會受到證監會所頒布的規則或規例所約束,包括(但不限於)客戶款項規則。閣下在決定買賣場外式黃金/白銀之前應審慎考慮自己的投資目標、交易經驗以及風險接受程度。可能出現的情況包括蒙受部分或全部初始投資額的損失,或在極端情況下(例如相關市場跳空)產生更多的損失。因此,閣下不應將無法承受損失的資金用於投資。投資應知悉買賣場外式黃金/白銀有關的一切風險,如有需要,請向獨立財務顧問尋求意見。